- Home
- CVKD vs DALN Comparison
CVKD vs DALN Comparison
Compare CVKD & DALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVKD
- DALN
- Stock Information
- Founded
- CVKD 2022
- DALN 1954
- Country
- CVKD United States
- DALN United States
- Employees
- CVKD N/A
- DALN N/A
- Industry
- CVKD Medicinal Chemicals and Botanical Products
- DALN Newspapers/Magazines
- Sector
- CVKD Health Care
- DALN Consumer Discretionary
- Exchange
- CVKD Nasdaq
- DALN Nasdaq
- Market Cap
- CVKD 20.8M
- DALN 24.6M
- IPO Year
- CVKD 2023
- DALN 2008
- Fundamental
- Price
- CVKD $16.17
- DALN $6.64
- Analyst Decision
- CVKD Strong Buy
- DALN
- Analyst Count
- CVKD 2
- DALN 0
- Target Price
- CVKD $46.00
- DALN N/A
- AVG Volume (30 Days)
- CVKD 79.1K
- DALN 79.0K
- Earning Date
- CVKD 11-07-2024
- DALN 11-12-2024
- Dividend Yield
- CVKD N/A
- DALN 2.41%
- EPS Growth
- CVKD N/A
- DALN N/A
- EPS
- CVKD N/A
- DALN N/A
- Revenue
- CVKD N/A
- DALN $128,286,000.00
- Revenue This Year
- CVKD N/A
- DALN N/A
- Revenue Next Year
- CVKD N/A
- DALN N/A
- P/E Ratio
- CVKD N/A
- DALN N/A
- Revenue Growth
- CVKD N/A
- DALN N/A
- 52 Week Low
- CVKD $5.40
- DALN $2.98
- 52 Week High
- CVKD $32.55
- DALN $6.99
- Technical
- Relative Strength Index (RSI)
- CVKD 61.78
- DALN 67.81
- Support Level
- CVKD $10.65
- DALN $4.78
- Resistance Level
- CVKD $12.25
- DALN $4.74
- Average True Range (ATR)
- CVKD 1.68
- DALN 0.46
- MACD
- CVKD 0.32
- DALN 0.16
- Stochastic Oscillator
- CVKD 76.54
- DALN 86.74
About CVKD Cadrenal Therapeutics Inc.
Cadrenal Therapeutics Inc is focused on developing a novel therapy with orphan drug indication, tecarfarin, for the prevention of systemic thromboembolism (blood clots) of cardiac origin in patients with end-stage renal disease (on dialysis) and atrial fibrillation (irregular heartbeat) or AFib. Tecarfarin is an anticoagulant designed using a drug design process that targets a different pathway than most commonly prescribed drugs for the treatment of thrombosis and AFib.
About DALN DallasNews Corporation Series A
DallasNews Corp is a local news and information publishing company in Texas with commercial printing, distribution, and direct mail capabilities, as well as a presence in emerging media and digital marketing.